Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for acute Charcot foot in diabetes
ACTRN12611000065998Phase 4Active, not recruiting
- Sponsor
- Pirkanmaa Hospital District
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of zoledronic acid in Charcot neuroarthropathy (CN) (2 arms), sponsored by Pirkanmaa Hospital District. Primary endpoint: Total immobilisation time in cast. Started Apr 2002; status: active, not recruiting.
02
Drugs
zoledronic acid
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on ACTRN12611000065998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000065998.